A mass rollout of weight loss injections begins across the NHS on Monday, with GPs able to prescribe Mounjaro for the first time. The drug, also known as tirzepatide and manufactured by Lilly, is an antidiabetic medication that works by lowering blood sugar levels and slowing down the digestion of food.

Around 220,000 people with "greatest need" are expected to receive Mounjaro, also known as tirzepatide and made by Lilly through the NHS over the next three years

Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who meet strict criteria. The move marks the beginning of a phases rollout of the weekly injection, which has been shown to help people lose up to 20% of their body weight.